Ignite Creation Date:
2025-12-24 @ 12:40 PM
Ignite Modification Date:
2025-12-27 @ 9:38 PM
Study NCT ID:
NCT03490461
Status:
COMPLETED
Last Update Posted:
2018-04-06
First Post:
2018-03-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
Sponsor:
Yonsei University
Organization:
Study Overview
Official Title:
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate whether statin therapy can help prevent recurrence of hepatocellular carcinoma (HCC) in transplant recipients who had liver transplantation for HCC. Multiple logistic regression analysis will be performed to evaluate the association between statin therapy and the risk of HCC recurrence after LT.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: